As prescription drug costs continue to frazzle Americans, lawmakers in several states are pushing to create commissions that would set prices that health plans, pharmacies, and state programs would pay for medicines, much like the rate-setting bodies that control public utilities.
Over the past year, legislation was introduced in three states — Maryland, New Jersey, and Minnesota — and advocacy groups are seeking legislators to introduce bills in at least two more states — Maine and Oregon — in coming weeks, according to sources familiar with the efforts.
Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!
GET STARTEDWhat is it?
STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.
What's included?
- Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
- Subscriber-only networking events and panel discussions across the country
- Monthly subscriber-only live chats with our reporters and experts in the field
- Discounted tickets to industry events and early-bird access to industry reports
About the Author
